Health Commissioner Olivér Várhelyi met with pharmaceutical and medtech industry groups to discuss competitiveness and upcoming EU legislation. Generics manufacturers warned about rising Asian competition and called for changes to wastewater pollution rules, while backing Parliament’s approach to the Critical Medicines Act. Talks with EFPIA and MedTech Europe also focused on key sector challenges and opportunities linked to the MDR/IVDR reform.